Cardiovascular Magnetic Resonance Imaging in Myocarditis

Progress in Cardiovascular Diseases

Volumn 54, Issue 3, 2011, Pages 266-275

  Childs, Helene ^a,b   Friedrich, Matthias G ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

CMR; Early gadolinium enhancement; Edema; Late gadolinium enhancement; MRI; Myocarditis; Noninvasive

Indexed keywords

GADOLINIUM; GALLIUM 67; INDIUM 111;

ACUTE CORONARY SYNDROME; ARTICLE; BLOOD ANALYSIS; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DYSPNEA; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FATIGUE; FOLLOW UP; HEART EDEMA; HEART INFARCTION; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HEART MUSCLE NECROSIS; HEART PALPITATION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HISTOPATHOLOGY; HUMAN; HYPEREMIA; IMAGE ANALYSIS; ISOTOPE LABELING; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SIGNAL DETECTION; STANDARDIZATION; THORAX PAIN;

CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDITIS; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 80054785048     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2011.09.003     Document Type: Article

References (81)

1. Jeserich M., Konstantinides S., Pavlik G., et al. Non-invasive imaging in the diagnosis of acute viral myocarditis. Clin Res Cardiol 2009, 98:753-763.
2. Friedrich M.G., Sechtem U., Schulz-Menger J., et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 2009, 53:1475-1487.
3. Cooper L.T. Myocarditis. N Engl J Med 2009, 360:1526-1538.
4. Caforio A.L.P., Mahon N.J., Tona F., et al. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 2002, 4:411-417.
5. Kleinert S., Weintraub R.G., Wilkinson J.L., et al. Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression. J Heart Lung Transplant 1997, 16:1248-1254.
6. Drory Y., Turetz Y., Hiss Y., et al. Sudden unexpected death in persons <40 years of age. Am J Cardiol 1991, 68:1388-1392.
7. Wesslén L., Påhlso C., Lindquist O., et al. An increase in sudden unexpected cardiac deaths among young Swedish orienteers during 1979-1992. Eur Heart J 1996, 17:902-910.
8. Doolan A., Langlois N., Semsarian C. Causes of sudden cardiac death in young Australians. Med J Aust 2004, 180:110-112.
9. Fabre A., Sheppard M.N. Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death. Heart 2006, 92:316-320.
10. Ramamurthy S., Talwar K.K., Goswami K.C., et al. Clinical profile of biopsy proven idiopathic myocarditis. Int J Cardiol 1993, 41:225-232.
11. Remes J., Helin M., Vaino P., et al. Clinical outcome and left ventricular function 23 years after acute coxsackie virus myopericarditis. Eur Heart J 1990, 11:182-188.
12. Kuhl U., Pauschinger M., Noutsias M., et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 2005, 111:887-893.
13. Jin O., Sole M., Butany J., et al. Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 1990, 82:8-16.
14. Martin A., Webber S., Fricker F., et al. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation 1994, 90:330-339.
15. Tracy S., Wiegand V., McManus B., et al. Molecular approaches to enteroviral diagnosis in idiopathic cardiomyopathy and myocarditis. J Am Coll Cardiol 1990, 15:1688-1694.
16. Wee L., Liu P., Penn L., et al. Persistence of viral genome into late stages of murine myocarditis detected by polymerase chain reaction. Circulation 1992, 86:1605-1614.
17. Baughman K.L. Diagnosis of myocarditis: death of Dallas criteria. Circulation 2006, 113:593-595.
18. Caforio A.L.P., Calabrese F., Angelini A., et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 2007, 28:1326-1333.
19. Esfandiarei M., McManus B.M. Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol 2008, 3:127-155.
20. Kadalie C.T. MRI in chronic myocarditis. Z Kardiol 2005, 94(Suppl 4):IV/94-96.
21. Liu P.P., Mason J.W. Advances in the understanding of myocarditis. Circulation 2001, 104:1076-1082.
22. Burke A.P., Saenger J., Mullick F., et al. Hypersensitivity myocarditis. Arch Pathol Lab Med 1991, 115:764-769.
23. Galiuto L., Enriquez-Sarano M., Reeder G.S., et al. Eosinophilic myocarditis manifesting as myocardial infarction: early diagnosis and successful treatment. Mayo Clin Proc 1997, 72:603-610.
24. Getz M.A., Subramanian R., Logemann T., et al. Acute necrotizing eosinophilic myocarditis as a manifestation of severe hypersensitivity myocarditis. Antemortem diagnosis and successful treatment. Ann Intern Med 1991, 115:201-202.
25. Cooper L.T., Berry G.J., Shabetai R. Idiopathic giant-cell myocarditis-natural history and treatment. N Engl J Med 1997, 336:1860-1866.
26. Menghini V.V., Savcenko V., Olson L.J., et al. Combined immunosuppression for the treatment of idiopathic giant cell myocarditis. Mayo Clin Proc 1999, 74:1221-1226.
27. Lieberman E.B., Hutchins G.M., Herskowitz A., et al. Clinicopathologic description of myocarditis. J Am Coll Cardiol 1991, 18:1617-1626.
28. D'Ambrosio A., Patti G., Manzoli A., et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 2001, 85:499-504.
29. Mason J.W., O'Connell J.B., Herskowitz A., et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995, 333:269-275.
30. Escher F., Westermann D., Gaub R., et al. Development of diastolic heart failure in a 6-year follow-up study in patients after acute myocarditis. Heart 2010, 706-714.
31. Bowles N.E., Ni J., Kearney D.L., et al. Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 2003, 42:466-472.
32. Dokainish H., Pillai M., Murphy S.A., et al. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy. J Am Coll Cardiol 2005, 45:19-24.
33. Larsen A.I., Galbraith P.D., Ghali W.A., et al. Characteristics and outcomes of patients with acute myocardial infarction and angiographically normal coronary arteries. Am J Cardiol 2005, 95:261-263.
34. Larson D.M., Menssen K.M., Sharkey S.W., et al. "False-positive" cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction. JAMA 2007, 298:2754-2760.
35. Jeremias A., Gibson C.M. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 2005, 142:786-791.
36. Gravanis M.B., Sternby N.H. Incidence of myocarditis. A 10-year autopsy study from Malmö, Sweden. Arch Pathol Lab Med 1991, 115:390-392.
37. Mahfoud F., Gartner B., Kindermann M., et al. Virus serology in patients with suspected myocarditis: utility or futility?. Eur Heart J 2011, 32:897-903.
38. Cooper L.T., Baughman K.L., Feldman A.M., et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J 2007, 28:3076-3093.
39. Morgera T., Di Lenarda A., Dreas L., et al. Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes. Am Heart J 1992, 124:455-467.
40. Assomull R.G., Lyne J.C., Keenan N., et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J 2007, 28:1242-1249.
41. Zaldumbide E.L., Pérez-David E., Larena J.A., et al. The value of cardiac magnetic resonance in patients with acute coronary syndrome and normal coronary arteries. Rev Esp Cardiol (English Edition) 2009, 62:976-983.
42. Baccouche H., Mahrholdt H., Meinhardt G., et al. Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease. Eur Heart J 2009, 30:2869-2879.
43. Thomas Aretz H. Myocarditis: the Dallas criteria. Hum Pathol 1987, 18:619-624.
44. Deckers J.W., Hare J.M., Baughman K.L. Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: a seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center. J Am Coll Cardiol 1992, 19:43-44.
45. Holzmann M., Nicko A., Kuhl U., et al. Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation 2008, 118:1722-1728.
46. Pophal S.G., Sigfusson G., Booth K.L., et al. Complications of endomyocardial biopsy in children. J Am Coll Cardiol 1999, 34:2105-2110.
47. Yilmaz A., Klingel K., Kandolf R., et al. Imaging in inflammatory heart disease: from the past to current clinical practice. Hellenic J Cardiol 2009, 50:449-460.
48. Lauer B. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol 1997, 30:1354-1359.
49. Pinamonti B., Alberti E., Cigalotto A., et al. Echocardiographic findings in myocarditis. Am J Cardiol 1988, 62:285-291.
50. Dec G.W., Palacios I., Yasuda T., et al. Antimyosin antibody cardiac imaging: its role in the diagnois of myocarditis. J Am Coll Cardiol 1990, 16:97-104.
51. Röttgen R., Christiani R., Freyhardt P., et al. Magnetic resonance imaging findings in acute myocarditis and correlation with immunohistological parameters. Eur Radiol 2011, 21:1259-1266.
52. Bruder O., Schneider S., Nothnagel D., et al. EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. J Am Coll Cardiol 2009, 54:1457-1466.
53. Abdel-Aty H., Simonetti O., Friedrich M.G. T2-weighted cardiovascular magnetic resonance imaging. J Magn Reson Imaging 2007, 26:452-459.
54. Friedrich M. Myocardial edema-a new clinical entity?. Nat Rev Cardiol 2010, 7:292-296.
55. Abdel-Aty H., Boyé P., Zagrosek A., et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005, 45:1815-1822.
56. Rutschow S., Leschka S., Westermann D., et al. Left ventricular enlargement in coxsackievirus-B3 induced chronic myocarditis-ongoing inflammation and an imbalance of the matrix degrading system. Eur J Pharmacol 2010, 630:145-151.
57. DiBona D.R., Powell W.J. Quantitative correlation between cell swelling and necrosis in myocardial ischemia in dogs. Circ Res 1980, 47:653-655.
58. Laine G.A., Allen S.J. Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function. Circ Res 1991, 68:1713-1721.
59. Zagrosek A., Abdel-Aty H., Boye P., et al. Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. J Am Coll Cardiol Img 2009, 2:131-138.
60. Desai K.V., Laine G.A., Stewart R.H., et al. Mechanics of the left ventricular myocardial interstitium: effects of acute and chronic myocardial edema. Am J Physiol Heart Circ Physiol 2008, 294:H2428-H2434.
61. Garcia-Dorado D., Oliveras J. Myocardial oedema: a preventable cause of reperfusion injury?. Cardiovasc Res 1993, 27:1555-1563.
62. Abdel-Aty H., Cocker M., Friedrich M.G. Myocardial edema is a feature of Tako-Tsubo cardiomyopathy and is related to the severity of systolic dysfunction: insights from T2-weighted cardiovascular magnetic resonance. Int J Cardiol 2009, 132:291-293.
63. Gutberlet M., Spors B., Thoma T., et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 2008, 246:401-409.
64. Friedrich M.G., Strohm O., Schulz-Menger J., et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998, 97:1802-1809.
65. Mewton N., Liu C.Y., Croisille P., et al. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 2011, 57:891-903.
66. Kim R.J., Fieno D.S., Parrish T.B., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999, 100:1992-2002.
67. Kim R.J., Wu E., Rafael A., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000, 343:1445-1453.
68. Rehwald W.G., Fieno D.S., Chen E.L., et al. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002, 105:224-229.
69. Mahrholdt H., Goedecke C., Wagner A., et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004, 109:1250-1258.
70. Röttgen R., Christiani R., Freyhardt P., et al. Magnetic resonance imaging findings in acute myocarditis and correlation with immunohistological parameters. Eur Radiol 2010, 21:1259-1266.
71. Skouri H.N., Dec G.W., Friedrich M.G., et al. Noninvasive imaging in myocarditis. J Am Coll Cardiol 2006, 48:2085-2093.
72. Sareban M., Steiner J., Murawski J., et al. Intra- and interobserver variability of different CMR-ratios for the detection of myocardial inflammation in patients with suspected acute viral myocarditis. J Cardiovasc Magn Reson 2010, 12(Suppl 1):P188.
73. Korkusuz H., Esters P., Huebner F., et al. Accuracy of cardiovascular magnetic resonance in myocarditis: comparison of MR and histological findings in an animal model. J Cardiovasc Magn Reson 2010, 12:49-54.
74. Eitel I., Lücke C., Grothoff M., et al. Inflammation in Takotsubo cardiomyopathy: insights from cardiovascular magnetic resonance imaging. Eur Radiol 2010, 20:422-431.
75. Eitel I., von Knobelsdorff-Brenkenhoff F., Bernhardt P., et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (Takotsubo) cardiomyopathy. JAMA 2011, 306:277-286.
76. Wassmuth R. Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot study. Am Heart J 2001, 141:1007-1013.
77. Mahrholdt H., Sechtem U. Noninvasive differentiation between active and healed myocarditis by cardiac magnetic resonance: are we there yet?. J Am Coll Cardiol Img 2009, 2:139-142.
78. Abdel-Aty H., Siegle N., Natusch A., et al. Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach. Lupus 2008, 17:561-567.
79. Schulz-Menger J., Wassmuth R., Abdel-Aty H., et al. Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance. Heart 2006, 92:399-400.
80. Vignaux O., Dhote R., Duboc D., et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis*. Chest 2002, 122:1895-1901.
81. Wagner A., Schulz-Menger J., Dietz R., et al. Long-term follow-up of patients with acute myocarditis by magnetic resonance imaging. MAGMA Magn Reson Mater Phys Biol Med 2003, 16:17-20.